Shengtao Liao

565 total citations
27 papers, 366 citations indexed

About

Shengtao Liao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Shengtao Liao has authored 27 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Shengtao Liao's work include Cancer-related molecular mechanisms research (5 papers), Inflammatory Bowel Disease (3 papers) and RNA modifications and cancer (3 papers). Shengtao Liao is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Inflammatory Bowel Disease (3 papers) and RNA modifications and cancer (3 papers). Shengtao Liao collaborates with scholars based in China. Shengtao Liao's co-authors include Li Gan, Lin Lv, Zhechuan Mei, Chuanfei Li, Qingshan Yang, Hongyu Quan, Yuanyuan Liu, Wenguang Zhang, Hongyu Chen and Shixiong Deng and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Life Sciences and Medicine.

In The Last Decade

Shengtao Liao

23 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengtao Liao China 10 219 136 59 43 26 27 366
Justyna Zińczuk Poland 14 137 0.6× 69 0.5× 54 0.9× 54 1.3× 7 0.3× 27 336
Zhiyuan Zhao China 9 151 0.7× 68 0.5× 64 1.1× 113 2.6× 6 0.2× 16 382
Geping Wu China 9 209 1.0× 145 1.1× 21 0.4× 34 0.8× 21 0.8× 21 388
Xue Zhao China 12 142 0.6× 77 0.6× 52 0.9× 26 0.6× 5 0.2× 34 342
Yuki Hirata Japan 11 151 0.7× 77 0.6× 90 1.5× 135 3.1× 11 0.4× 51 475
Yuxin Hu China 12 238 1.1× 174 1.3× 129 2.2× 47 1.1× 4 0.2× 30 511
Jieshuang Jia China 11 382 1.7× 52 0.4× 17 0.3× 35 0.8× 5 0.2× 19 565
María Pimentel-Santillana Spain 8 189 0.9× 77 0.6× 27 0.5× 33 0.8× 13 0.5× 10 435
Yajie Yu China 11 118 0.5× 61 0.4× 38 0.6× 51 1.2× 4 0.2× 36 337

Countries citing papers authored by Shengtao Liao

Since Specialization
Citations

This map shows the geographic impact of Shengtao Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengtao Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengtao Liao more than expected).

Fields of papers citing papers by Shengtao Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengtao Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengtao Liao. The network helps show where Shengtao Liao may publish in the future.

Co-authorship network of co-authors of Shengtao Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Shengtao Liao. A scholar is included among the top collaborators of Shengtao Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengtao Liao. Shengtao Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhan, Ke, Chuanfei Li, Li Gan, et al.. (2025). Long non-coding RNA ANRIL/p65 negative feedback loop protects intestinal barrier function in inflammatory bowel disease. Non-coding RNA Research. 12. 167–179. 1 indexed citations
2.
Hu, Chun‐Li, Shengtao Liao, Liang Zhang, et al.. (2025). Neutrophil-macrophage hybrid membrane-coated prussian blue nanozyme for ulcerative colitis treatment and mechanistic insights. Journal of Nanobiotechnology. 23(1). 43–43. 8 indexed citations
3.
Zhang, Lin, Li Gan, Yu‐Ru Lin, Zhechuan Mei, & Shengtao Liao. (2025). FTO Promotes Hepatocellular Carcinoma Progression by Mediating m6A Modification of BUB1 and Targeting TGF-βR1 to Activate the TGF-β Signaling Pathway. Journal of Clinical and Translational Hepatology. 0(0). 0–0.
4.
5.
6.
7.
Wang, Shuling, et al.. (2024). FEN1 upregulation mediated by SUMO2 via antagonizing proteasomal degradation promotes hepatocellular carcinoma stemness. Translational Oncology. 44. 101916–101916. 3 indexed citations
8.
Liao, Shengtao, et al.. (2023). Intestinal Immune Imbalance is an Alarm in the Development of IBD. Mediators of Inflammation. 2023. 1–17. 16 indexed citations
9.
Liao, Shengtao, et al.. (2023). Establishment of a lipopolysaccharide-induced inflammation model of human fetal colon cells. Molecular Biology Reports. 50(7). 5557–5564. 5 indexed citations
10.
Zhan, Ke, Lu Zeng, Shengtao Liao, et al.. (2023). Peroxisomal trans-2-enoyl-CoA inhibits proliferation, migration and invasion of hepatocellular carcinoma cells. Acta Histochemica. 125(2). 152002–152002. 1 indexed citations
11.
Li, Chuanfei, Ya Song, Yu‐Ru Lin, et al.. (2023). Long Non-Coding RNA ANRIL Regulates Inflammatory Factor Expression in Ulcerative Colitis Via the miR-191-5p/SATB1 Axis. Inflammation. 47(2). 513–529. 4 indexed citations
12.
Shi, Shasha, Xi Zheng, Lin Lv, et al.. (2022). Visualization system based on hierarchical targeting for diagnosis and treatment of hepatocellular carcinoma. Materials Today Bio. 16. 100398–100398. 5 indexed citations
13.
Liao, Shengtao, et al.. (2021). Potential mechanisms of cerebrovascular diseases in COVID-19 patients. Journal of NeuroVirology. 27(1). 35–51. 23 indexed citations
14.
Gan, Li, Shengtao Liao, Yu Xing, & Shixiong Deng. (2021). The Regulatory Functions of lncRNAs on Angiogenesis Following Ischemic Stroke. Frontiers in Molecular Neuroscience. 13. 613976–613976. 19 indexed citations
15.
Liao, Shengtao, Li Gan, Lin Lv, & Zhechuan Mei. (2020). The regulatory roles of aquaporins in the digestive system. Genes & Diseases. 8(3). 250–258. 23 indexed citations
16.
Liu, F.C., Wenguang Zhang, Xi Zheng, et al.. (2020). AQP9 suppresses hepatocellular carcinoma cell invasion through inhibition of hypoxia‐inducible factor 1α expression under hypoxia. Journal of Gastroenterology and Hepatology. 35(11). 1990–1997. 9 indexed citations
17.
Liao, Shengtao, Hongyu Chen, Min Liu, et al.. (2020). Aquaporin 9 inhibits growth and metastasis of hepatocellular carcinoma cells via Wnt/β-catenin pathway. Aging. 12(2). 1527–1544. 52 indexed citations
18.
Liao, Shengtao, et al.. (2019). Clinical application of combined laparoscopic surgery in the treatment of primary hepatocellular carcinoma with portal hypertension: a report of 16 cases. Translational Cancer Research. 8(1). 330–337. 2 indexed citations
19.
Gan, Li, Lin Lv, & Shengtao Liao. (2019). Long non‑coding RNA H19 regulates cell growth and metastasis via the miR‑22‑3p/Snail1 axis in gastric cancer. International Journal of Oncology. 54(6). 2157–2168. 63 indexed citations
20.
Liu, Yuanyuan, et al.. (2016). Involvement of microRNA-135a-5p in the Protective Effects of Hydrogen Sulfide Against Parkinson's Disease. Cellular Physiology and Biochemistry. 40(1-2). 18–26. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Justyna Zińczuk Breakdown of academic impact, for papers by Zhiyuan Zhao Breakdown of academic impact, for papers by Geping Wu Breakdown of academic impact, for papers by Xue Zhao Breakdown of academic impact, for papers by Yuki Hirata Breakdown of academic impact, for papers by Yuxin Hu Breakdown of academic impact, for papers by Jieshuang Jia Breakdown of academic impact, for papers by María Pimentel-Santillana Breakdown of academic impact, for papers by Yajie Yu
Rankless by CCL
2026